ZBIO compared with MBX: revenue, margins and what each company keeps, and the suppliers and customers both name

ZBIOZenas BioPharma, Inc.

Mkt capRevenueRevenue

MBXMBX Biosciences, Inc.

Mkt capRevenueRevenue

Compare

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Revenue flow

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Price

Supply-chain overlap

Revenue flow

ZBIO: latest quarter is a loss; flow not drawable. MBX: latest quarter not drawable.Method ›

ZBIOZenas BioPharma, Inc.

28.80▲+4.28%

Mkt cap$1.7BRevenue$1MQ2 FY26

MBXMBX Biosciences, Inc.

56.40▲+3.67%

Regular sessionNov 3 '26

Mkt cap$2.6BRevenue—

Compare

Regular sessionNov 3 '26

ZBIOZenas BioPharma, Inc.

MBXMBX Biosciences, Inc.

28.80▲+4.28%

Price

56.40▲+3.67%

$1.7B

Mkt cap

$2.6B

Q2 FY26$1M

Revenue

—

ZBIO28.80▲+4.28%vsMBX56.40▲+3.67%Regular sessionNov 3 '26

Price

rebased to 0%

ZBIO, solidMBX, dashed

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only ZBIO 10

BMYBristol-Myers Squibbcustomer

XNCRXencorsupplier

—InnoCareunlistedsupplier

—WuXi Biologicsunlistedsupplier

6 more · ZBIO chain ›

Shared 0

No shared counterparties.

Only MBX 3

—Dr. Richard DiMarchiunlistedsupplier

—Indiana University Research and Technology Corporation ("IURTC")unlistedsupplier

—Trustees of Indiana Universityunlistedsupplier

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR